🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the UK / NCT07133477
Recruiting Not applicable

A Study to Evaluate the Effect of Fish Oil Concentrate on Skin Function

NCT07133477 · tracked via the Priya Life Science UK tracker
Sponsor
Epax Norway AS
Phase
Not applicable
Started
2025-04-30
Last updated
2025-08-21

Condition(s) studied

Skin Health

Investigational drug(s) / intervention(s)

Omega 3-9-11Placebo

Omega 3-9-11: Fish oil capsules containing a fish oil concentrate from North Atlantic fish species containing EPA / DHA / cetoleic acid and gondoic in controlled amounts.

Placebo: Corn oil capsules

Study summary

The primary objective of the study is to determine the benefits of the food product EPAX Omega 3-9-11 on skin function.

Benefits (if any) will be determined by evaluating biophysical measurements of the face and inner forearm. Moreover, the study will determine the dosage effect of Omega-3-9-11 on these measurements.

Eligibility

Sex
ALL
Min age
35 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Volunteers who are able to provide signed informed consent * Healthy male or female volunteers between the ages of 35 and 65 years * Volunteers with a self-perceived history of atopic skin, prone to redness and/or dryness Exclusion Criteria: * Females who are pregnant, breast feeding, or have given birth within the previous 6 weeks or are planning to be pregnant during the study * Volunteers with previous experience of intolerance or allergic reactions to fish or fish products * Volunteers with an active skin disorder or a significant history of skin disorders (e.g. psoriasis, eczema, vitiligo, pityriasis versicolor, acne) which in the opinion of a trained assessor or dermatologist may affect the test results * Volunteers currently taking or who have recently taken antihistamines, antibiotics, systemic anti-inflammatory drugs during the previous week * Volunteers currently taking or who have recently taken retinoids, immunosuppressive drugs, anti-cancer drugs during the six previous months * Volunteers who have started, stopped or changed hormonal treatment (including contraceptive pills) in the five previous weeks * Volunteers whose skin has been exposed to excessive levels of sun or UV rays during the previous month * Volunteers who are suffering from chronic asthma, a malfunction of the lymphatic system, or an auto immune deficiency disease (e.g. lupus, thyroiditis) * Volunteers with a history of skin tumours or malignant disease * Volunteers who have participated in any clinical study involving the test sites within the previous month * Volunteers taking fish oil supplements or other lipid-based supplements regularly during the last 4 weeks

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cutest Systems Ltd Cardiff United Kingdom Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07133477 on ClinicalTrials.gov ↗ ← All trials in the UK